Exelixis (EXEL) Non-Current Assets (2010 - 2026)

Exelixis (EXEL) recorded quarterly Non-Current Assets of $1.4 billion in Q2 2026, down 1.15% quarter-over-quarter from $1.4 billion in Q1 2026, and down 3.87% on a YoY basis from $1.4 billion in Q2 2025.

Exelixis (EXEL) Non-Current Assets (2010 - 2026) Analysis & Trends

Exelixis' Non-Current Assets history runs 17 years deep, the most recent figure standing at $1.4 billion for Q2 2026.

  • In Q2 2026, Non-Current Assets fell 3.87% year-over-year to $1.4 billion; the TTM figure through Apr 2026 stood at $5.7 billion (up 1.38% YoY), while the FY2026 annual figure was $1.4 billion, down 5.34% from the prior year.
  • Non-Current Assets was $1.4 billion for Q2 2026 at Exelixis, down from $1.4 billion in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $1.6 billion in Q4 2023 to a low of $811.4 million in Q2 2022.
  • Historically, Non-Current Assets has averaged $1.4 billion across 5 years, with a median of $1.4 billion in 2025.
  • The sharpest annual moves came in 2022 and 2024: Non-Current Assets jumped 85.89% in 2022, then declined 16.51% in 2024.
  • A 5-year view of Non-Current Assets shows it stood at $1.5 billion in 2022, then rose by 11.82% to $1.6 billion in 2023, then decreased by 13.16% to $1.4 billion in 2024, then climbed by 0.76% to $1.4 billion in 2025, then decreased by 2.56% to $1.4 billion in 2026.
  • The last three Non-Current Assets figures came in at $1.4 billion (Q2 2026), $1.4 billion (Q1 2026), and $1.4 billion (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 62,953.78
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - 289.41 Mn
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 4.56 Mn
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 486.60 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 30.30 Mn
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 14.75 Bn
9 Abivax 94.37 Bn 94.37 Bn - 39.71 Mn
10 Exelixis 13.37 Bn 12.59 Bn 590.86 Mn 1.38 Bn

Historic Data

Download Data
DateValue
Apr 3, 2026 1.38 Bn
Jan 2, 2026 1.40 Bn
Oct 3, 2025 1.42 Bn
Jul 4, 2025 1.50 Bn
Apr 4, 2025 1.44 Bn
Jan 3, 2025 1.48 Bn
Sep 27, 2024 1.41 Bn
Jun 28, 2024 1.30 Bn
Mar 29, 2024 1.51 Bn
Dec 29, 2023 1.62 Bn
Sep 29, 2023 1.53 Bn
Jun 30, 2023 1.55 Bn
Mar 31, 2023 1.51 Bn
Dec 30, 2022 1.45 Bn
Sep 30, 2022 1.12 Bn
Jul 1, 2022 1.03 Bn
Apr 1, 2022 811.38 Mn
Dec 31, 2021 781.49 Mn
Oct 1, 2021 785.71 Mn
Jul 2, 2021 774.03 Mn